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Background: The purpose of this study was to analyze the hospital, clinical, and patient factors associated
with inpatient readmission after total knee arthroplasty (TKA) in the Medicare population and to un-
derstand the primary reasons for readmission.
Methods: The Medicare 100% national hospital claims database was used to identify 952,593 older pa-
tients (65þ) with a primary TKA in 3848 hospitals between 2010 and 2013. A multilevel logistic
regression analysis with a clustered data structure was used to investigate the risk of all-cause 30- and
90-day readmission, incorporating hospital, clinical, and patient factors.
Results: At 30 days, readmission ranged from 0% to 22% (median, 4.9%), whereas at 90 days, readmission
ranged from 0% to 32% (median, 8.6%). Geographic census region, hospital procedure volume, rural
hospital location, and nonproﬁt ownership were the only signiﬁcant hospital factors among those we
studied. Evaluation of clinical factors showed use of a perioperative transfusion was associated with 13%
greater risk; patients discharged to home had 25% lower risk; and surgeon volume and length of stay
were also signiﬁcant. These effect sizes were at least comparable to patient factors, such as age, gender,
comorbidities, and socioeconomic status. The top 5 most frequently reported primary reasons for 30- or
90-day readmission in TKA were surgery and medical related: wound infection, deep infection, atrial
ﬁbrillation, cellulitis and abscess of leg, or pulmonary embolism.
Conclusion: The results of this study support further optimization of anti-infection measures, both
intraoperative and postoperative, to reduce the broad variation in hospital readmissions.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Stryker Orthopaedics.
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Inc. This is an open access article uHealth care reform and the Patient Protection and Affordable
Care Act of 2010 (ACA) have introduced all-cause hospital read-
mission as an important metric for the quality of care across several
ﬁelds of surgery, including orthopedics. Both 30-day and 90-day
readmissions rates after primary total knee arthroplasty are rele-
vant hospital benchmarks in today's era of health care reform,
although for slightly different reasons. The 30-day, all-cause, risk-
standardized readmission rate after total hip and knee arthroplasty
(THA and TKA) is evaluated by the Center of Medicare andMedicaid
(CMS) as a quality measure for individual hospitals and is available
as an online search tool for prospective patients (https://www.
medicare.gov/hospitalcompare/search.html). Under the provisions
of the ACA, which were extended in 2015 to speciﬁcally include
readmission after primary TKA, hospitals will be penalized to thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
CMS LDS Inpatient Data 2010-2013.
Effect Level TKA Readmit Readmit % TKA % Readmit
30 d 90 d 30 d 90 d
Total 952,593 47,268 79,536 100.0 100.0 100.0
Age, y 65-69 306,952 11,747 19,847 32.2 24.9 25.0
70-74 276,702 12,443 20,690 29.0 26.3 26.0
75-79 208,503 11,553 19,395 21.9 24.4 24.4
80-84 118,314 7957 13,475 12.4 16.8 16.9
85þ 42,122 3568 6129 4.4 7.5 7.7
Charlson
Index
00 519,176 20,282 33,654 54.5 42.9 42.3
1-2 357,109 19,891 33,687 37.5 42.1 42.4
3-4 63,864 5474 9289 6.7 11.6 11.7
5þ 12,444 1621 2906 1.3 3.4 3.7
Discharge
type
Home 190,784 6813 11,102 20.0 14.4 14.0
Home w/HHS 334,760 12,597 20,636 35.1 26.7 25.9
Other facility 10,506 2469 2930 1.1 5.2 3.7
Rehab facility 99,135 6610 11,359 10.4 14.0 14.3
SNF 317,408 18,779 33,509 33.3 39.7 42.1
Hospital
annual
TJA volume
001-149 214,301 11,972 19,889 22.5 25.3 25.0
150-299 269,863 13,554 22,988 28.3 28.7 28.9
300-449 173,260 8390 14,049 18.2 17.7 17.7
450-599 114,122 5305 8976 12.0 11.2 11.3
600þ 181,047 8047 13,634 19.0 17.0 17.1
Hospital beds 001-149 233,313 11,968 19,271 24.5 25.3 24.2
150-299 267,179 13,170 22,330 28.0 27.9 28.1
300-499 238,594 11,653 20,112 25.0 24.7 25.3
500þ 213,507 10,477 17,823 22.4 22.2 22.4
Hospital
ownership
Nonproﬁt 160,976 8504 14,128 16.9 18.0 17.8
Private 678,473 33,204 56,144 71.2 70.2 70.6
Public 113,144 5560 9264 11.9 11.8 11.6
Hospital
setting
Rural 133,329 6728 11,365 14.0 14.2 14.3
Urban 819,264 40,540 68,171 86.0 85.8 85.7
Hospital stay 1-2 167,835 6482 10,081 17.6 13.7 12.7
3-4 704,341 33,271 56,647 73.9 70.4 71.2
5þ 80,417 7515 12,808 8.4 15.9 16.1
Hospital
teaching
No 682,703 33,642 56,502 71.7 71.2 71.0
Yes 269,890 13,626 23,034 28.3 28.8 29.0
Race Black 49,832 2987 5102 5.2 6.3 6.4
Oth/Unk 35,090 1734 2890 3.7 3.7 3.6
White 867,671 42,547 71,544 91.1 90.0 90.0
Resident
region
Midwest 261,330 13,103 22,197 27.4 27.7 27.9
North East 148,100 8041 13,224 15.5 17.0 16.6
South 374,983 18,930 31,888 39.4 40.0 40.1
West 168,180 7194 12,227 17.7 15.2 15.4
Gender Female 604,412 27,431 48,046 63.4 58.0 60.4
Male 348,181 19,837 31,490 36.6 42.0 39.6
Patients undergoing total knee arthroplasty and rehospitalized (all cause) in 30 or
90 days. Demographic proﬁle and hospital characteristics of primary and readmitted
patients.
HHS, home health service; LDS, limited data set; SNF, skilled nursing facility; TJA,
total joint arthroplasty; TKA, total knee arthroplasty.
S.M. Kurtz et al. / The Journal of Arthroplasty 31 (2016) 2099e21072100extent that they have “excess” 30-day readmissions. Themagnitude
of the ﬁnancial penalty ranges from 1% to 3% of the hospital
reimbursement for the TKA surgery. Bundling of health services
into an episode of care is another innovation of health care reform
and the ACA. As payers including CMS move forward with imple-
menting a bundled payment system, hospitals will be accountable
for the costs of readmissions for any reason, up to 90 days from
discharge. As orthopedic surgeon and hospital interests will be
increasingly aligned in a bundled payment system, both parties
have incentive to reduce all-cause 30- and 90-day hospital read-
missions after TKA [1].
Despite the growing inﬂuence of health care reforms, such as
these new readmission rules, on the practice of orthopedic surgery
and patient care, relatively few recent studies have investigated the
national hospital level of readmission after total knee arthroplasty
and factors that explain interhospital and intrahospital variation.
Cram et al [2] observed a trend of increasing hospital 30-day
readmissions for Medicare beneﬁciaries between 1991 and 2010,
coincident with a trend of decreasing length of stay (LOS), sug-
gesting that perhaps a patient's failure to cope with early discharge
may be partly responsible for the readmission trend [3]. By
analyzing data from a single institution, Mesko et al [4] found that
increased risk of 30-day readmission was predicted by longer LOS,
discharge to a nursing facility, blood transfusion, general anes-
thesia, and anticoagulation therapy, as well as Charlson Comor-
bidity Index greater than 2. Singh et al [5] showed that rheumatoid
arthritis is a risk factor for 90-day readmission, whereas Raines et al
[6] found that hospital acquired conditions were responsible for
over 40% of 30-day readmissions. Pugely et al [7] analyzed the
American College of Surgeons National Surgical Quality
Improvement Program database and identiﬁed several patient
factors (eg, age, gender, cancer history) that were associated with
30-day readmission after TKA. Overall, previous studies of read-
missions after TKA have either focused on the patient as the unit of
analysis across multiple hospitals [2,5-7] or a group of patients
within a single hospital setting [4,8].
To add to the knowledge base on 30- and 90-day readmissions
after TKA, we studied the hospital as the unit of analysis and asked
the following research questions for the Medicare population of
primary TKA patients: (1) Which hospital factors inﬂuence 30-day
and 90-day readmission after primary TKA? (2) Which clinical
factors inﬂuence 30- and 90-day readmission? (3) What are the
principal reasons for 30- and 90-day hospital readmission and are
they procedure related?
Materials and Methods
The Medicare 100% national hospital claims were used to
identify 952,593 elderly patients (aged 65þ years) with a primary
TKA in 3848 hospitals between 2010 and 2013 (Table 1). The
Medicare data captured claims submitted for patients enrolled in
the traditional fee-for-service program, which did not include re-
cords of medical service provided to beneﬁciaries enrolled in
Medicare advantage or other Health Maintenance Organization-
type plans. Primary TKA procedures were identiﬁed using Inter-
national Classiﬁcation of Diseases, 9th rev., Clinical Modiﬁcation code
81.54. Patients younger than 65 years old, enrolled in a Health
Maintenance Organization, or residing outside the 50 US states
were excluded.
We used a 1-year look-back period before the index TKA to
compute patient factors, including comorbidities, hospital volume,
and surgeon volume. These volume measures were limited to the
Medicare population, and as a proxy for experience, were assumed
to correlate well with the overall volume of the hospital or of the
surgeon. For those patients who received their primary TKA in2010, we used the 100% inpatient data from 2009 for the look-back
period. Patients were tracked longitudinally for up to 30 and 90
days after their primary TKA procedure. Patients who died within
the 30-day or the 90-day period without encountering readmission
were considered censored, because they did not have the oppor-
tunity to be readmitted. We determined readmission as the
appearance of new hospital claims record for the patient within 30
or 90 days of the patient's discharge date. Patients who returned to
the hospital only for rehabilitation service (International Classiﬁ-
cation of Diseases, 9th rev., Clinical Modiﬁcation V57.x) and not
associated with complications or other medical issues were not
included.
Fig. 1. Geographic variation in (A) 30-day and (B) 90-day all-cause hospital readmission after TKA by state and county in the 100% Medicare data set (2010-2013). TKA, total knee
arthroplasty.
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Fig. 2. Relative signiﬁcance of patient, hospital, and clinical factors for 30-day readmission after TKA. CMS, Center of Medicare and Medicaid; LDS, limited data set.
Fig. 3. Relative signiﬁcance of patient, hospital, and clinical factors for 90-day readmission after TKA.
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structure was used. The “multilevel” approach used detailed (in-
dividual) level factors (eg, age, gender, comorbidity) and group
level (hospital) factors (eg, bed size, type of hospital) in the same
model, whereas the logistic regression approach involved analyzing
a binary outcome (readmitted or not readmitted). Using a “clus-
tered” approach, patients were grouped or clustered by the hospital
inwhich theywere treated. Thus, we accounted for thosewhowere
treated in the same hospital and shared a common institutional-
level risk of readmission, above and beyond their personal risk
factors. These clustered recordswere captured as a hospital random
effect (ie, a random intercept) for each hospital, and the additional
risk factors were added to the overall hospital level.
We studied the hospital geographic location (rural/urban), bed
size, type of hospital (eg, proﬁt vs nonproﬁt, teaching vs
nonteaching) as hospital factors, and LOS, discharge status (home
vs skilled nursing facility), and use of transfusion as clinical factors.
We included the following individual patient factors: age, gender,
race, census region, Medicare buy-in status (a proxy for socioeco-
nomic status), Charlson comorbidity score, and the presence of one
or more speciﬁc comorbidities including anemia, depression, dia-
betes, drug/alcohol abuse, heart failure, lymphoma, obesity, pul-
monary condition, renal disease, and/or the diagnosis of a
secondary tumor.
Statistical analyses were performed using the SAS statistical
software, Release 9.4 (Cary, NC). Results were considered signiﬁcant
for statistical tests with P < .05. The sample size in this study wasFig. 4. Principal diagnosis associated wconsiderably larger than most TKA studies using data from a single
institution or practice. As a result, most factors, even with only
modest association with the outcome, were found to be highly
signiﬁcant, as conventionally expressed by the P value. For many
factors with the same signiﬁcant P value (eg,<.0001), we examined,
in addition, the type III tests of ﬁxed effect as measured by the F-
statistics, as an indicator for the relative importance of these hos-
pital and patient factor on 30-day or 90-day readmission. The type
III F-statistics of a particular factor measures the additional
reduction in the error variance after all the other factors had been
included. It thus reﬂects the factor's independent contribution to-
ward accounting for the variations in the dependent variable. The
type III F-statistic is valid for unbalanced data, which is typical in
observational data sources used in such investigations.
Results
We observed wide variation in hospital readmission 30 days
after TKA (range: 0%-22%, average ± SD: 5.8 ± 6.5%, median: 4.9%)
and 90 days after TKA (range: 0%-32%, average ± SD: 9.6 ± 7.7%,
median: 8.6%). This interhospital variation was signiﬁcantly based
on their geography (Fig. 1). Patients in the west had the lowest
readmission rates (4.3%, 30 days; 7.3%, 90 days). Other census re-
gions had 30-day readmission rate at 5.0%-5.4%, and 90-day rates at
8.5%-8.9%. Relative to the West, these rates were 9%-12% (30 days)
and 6%-11% (90 days) higher, after adjusting for other factors (P <
.0001). In addition to geography, hospital volume (P < .0001), ruralith 30-day readmission after TKA.
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ownership (odds ratio: 1.10 vs public ownership, P < .0001) were
only other signiﬁcant hospital factors for 30-day readmission
among those we studied (Fig. 2). Size of the hospital (P ¼ .078) and
the hospital's teaching status (P¼ .31) were not associated with risk
of readmission. Hospital volume and nonproﬁt ownership hospital
factors and 90-day readmission were also observed (Fig. 3).
Overall, patients' clinical factors had amuch stronger association
with the risk of 30-day readmission than general hospital factors, as
shown by the relative values in the F-statistics for each variable in
Figures 2 and 3. Use of a transfusionwas associatedwith 13% greater
risk (P < .0001); each additional surgeon volume of 100 procedures
had 6% less risk (P < .0001); patients discharged to home had 25%
less risk (P < .001); and shorter LOS was associated with up to 29%
reduction of risk (P < .0001), with 1- to 2-day and 3- to 4-day LOS
having the lowest risk as compared with 5þ days. Based on the F-
statistics, these effect sizeswere at least comparable to other equally
signiﬁcant but unmodiﬁable patient factors, such as age, gender,
comorbidities, and socioeconomic status (Figs. 2 and 3).
The top 5 most frequently reported primary reasons for 30-day
readmission in TKA were surgery and medical related (Fig. 4):
wound infection (6.2%), deep infection (4.5%), atrial ﬁbrillation
(3.9%), cellulitis and abscess of leg (3.0%), or pulmonary embolism
(2.6%). The top 5 reasons for 90-day readmission were the same as
those at 30 days (Fig. 5). The top 5 most commonly reported pri-
mary procedures during readmission before 30 days were (Fig. 6):
transfusion of packed cells (12.7%); tibial insert exchange (4.7%);Fig. 5. Principal diagnosis associated wesophagogastroduodenoscopy (4.5%); arthrocentesis (4.4%); and
venous catheterization (4.3%). The top 5 most commonly reported
primary procedures during readmission before 90 days were the
same as those at 30 days (Fig. 7).
Discussion
Health care reform has established the risk-adjusted rate of all-
cause hospital readmission as an important benchmark of the
quality of care for TKA and is one of the factors directly linked with
hospital reimbursement and bundled care payments. The interest
of both the surgeon and the hospital should be aligned to identify
innovations that will mitigate factors associated with the broad
interhospital and clinical variations we observed for 30- and 90-day
readmission. These data suggest that a multipronged approach is
warranted to reduce readmissions, as the associations we observed
implicate hospital, clinical, and patient factors.
One limitation of our work is that the administrative data and
patient management metrics captured by Medicare may less
accurately represent short-term outcomes than does the data in
clinical studies designed to capture nonessential diagnoses and
comorbidities. However, these are the exact same administrative
data that CMS is using to deﬁne the risk-standardized readmission
rate as a benchmark to determine whether a hospital has an
“excess” number of readmissions. Although the research team
working with CMS has published the methodology for calculating
risk-standardized complications and readmissions [9], whichith 90-day readmission after TKA.
Fig. 6. Most commonly performed procedures during 30-day readmission after TKA.
S.M. Kurtz et al. / The Journal of Arthroplasty 31 (2016) 2099e2107 2105include patient factors, we were interested in comparing the effect
of patient factors, such as age and gender, with the effect of clinical
and hospital factors associated with readmission after TKA. It
should be noted that our data are limited to TKA procedures per-
formed between 2010 and 2013. As data from Cram showed by
analyzing Medicare data between 1991 and 2010, there can be
changes in readmission rates over time, and we would expect the
period after the introduction of the ACA in 2010 to stimulate
additional changes in the rates of readmission in future years.
Offsetting these limitations, our study includes the totality of TKA
surgeries reimbursed by Medicare in the most recent 4-year win-
dow of available data. This data set captures the outcomes for
almost a million patients with essentially 100% follow-up. Because
patients can be tracked over time in the Medicare data set, even if
they were readmitted to a different hospital than the hospital in
which the index TKA surgery was performed, these data have a
major advantage over retrospective studies of this topic at a single
institution where patients frequently are lost to follow-up. Finally,
because national policy established by CMS and other federal
agencies such as Agency of Healthcare Quality and Research is
based on analysis of Medicare data, our use of the same data source
in this research is another major strength of the present study.
Few studies have examined the role of hospital factors and
readmission rates in joint arthroplasty. Paxton et al [10], who
examined the role of patient, clinical, and hospital factors in 30-day
readmission after total hip arthroplasty, found that hospital volume
was a signiﬁcant covariate. Similarly, we also found an effect ofhospital procedure volume on 30- and 90-day readmission.We also
identiﬁed the geographic location of a hospital as an independent
risk factor, with hospitals located in the West exhibiting signiﬁ-
cantly lower readmission rates compared with other regions of the
United States. The reasons underlying this systematic reduction
remain unclear, andmore advanced statistical modeling techniques
that account for propensity of surgery, patient selection bias, or an
instrumental variables approach could help better elucidate this
ﬁnding. Such advanced techniques, however, were beyond the
scope of the present study.
Previous single-center studies have identiﬁed clinical factors as
impacting readmission rates. The study by Mesko [4], for example,
found that LOS, discharge disposition, blood transfusion, the type of
anesthesia and anticoagulation therapy were all predictors of 30-
day readmission after TKA. We found a similar association with
discharge disposition and anticoagulation therapy, however, our
ﬁndings with LOS differed somewhat, in that in our analysis, only
patients with a LOS of 5 or more days were associated with higher
risk of readmission. The higher LOS would indicate a patient with a
more complicated course of recovery after their primary TKA [11]. A
preoperative discussionwith patients to address LOS and discharge
disposition may lead to less readmissions [12]. If patients and
families are aware of the reduced complication rate associated with
a shorter LOS and home discharge they may be able to modify
routines and allow family members to convalesce at home.
The study by Pugely et al [7], which reported that wound
infection, sepsis, and patient factors were major causes of 30-day
Fig. 7. Most commonly performed procedures during 90-day readmission after TKA.
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infection, together with general medical complications unrelated to
orthopedic surgery, was most often reported to CMS as reasons for
readmission after TKA. In light of the impressive variability we
observed among hospitals across the US, the results of this study
suggest that focus on anti-infection strategies and setting the
expectation for a home discharge will be useful to reduce read-
mission rates after TKA. As with previous single-center studies
[3,12,13], we also observed that medical- and surgery-related fac-
tors were most often reasons for readmission after TKA in the
Medicare population. Jordan et al [14] developed a program of
addressing outpatient venous thromboembolism, together with
treatment of surgical site infection and education of physicians to
increase awareness of complications after TJR and managed to
reduce readmissions after TKA from 3.3% to 2.2%. Keeney et al [12]
have recently described the results of a multipronged complication
reduction initiative in their hospital system between 2010 and
2013, including an emphasis on postoperative wound care after
primary TKA. They found that their institution's all-cause 30-day
readmission rate after TKA decreased from 5.0% to 3.0% as a
result of their new approach to improving patient care and
reducing complications after surgery. Thus, several studies would
indicate that hospital readmission rates can be effectively reduced
by a variety of pathways.
Overall, our ﬁndings support further optimization of anti-
infection measuresdboth intraoperatively and postoperativelydto reduce the broad variation in hospital readmissions we observed
after primary TKA. Hospitals and surgeons will need to work
closely together to decrease the likelihood of a readmission because
the hospital is at risk under the new global pricing program
beginning January 1, 2016. It will be interesting to see how these
policy changes play out, as the new reimbursement rules for
readmission could adversely affect patient and surgeon access to
joint arthroplasty in the future. Beyond anti-infection procedures,
the data presented in this article identify additional hospital,
clinical, and patient factors that can be used to identify not only “at-
risk” patients but also “at-risk” hospital proﬁles. We trust that
attention to these various factors will point to adjustments in
clinical and hospital practices that may minimize readmissions in
the future and allow all patients continued access to total knee
arthroplasty.References
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